Brian LaMoreaux

16PUBLICATIONS
23CO-AUTHORS
Nanotoxicology, health and safetyCardiology (incl. cardiovascular diseases)NaturopathyPharmacogenomicsCross-sectional analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 23, 2026
Tolerance of methotrexate co-administered with pegloticase in patients with uncontrolled gout: overview of the findings from the mirror RCT.

|Apr 17, 2026
Gout prevalence and management strategies among patients with moderate to advanced chronic kidney disease.

|Sep 19, 2025
The Impact of Uncontrolled Gout on Healthcare Utilization and Health Outcomes for United States Veterans Affairs Patients.

Adriana Vargus, Corbyn M Gilmore, Jim M Koeller

|May 20, 2025
Oral Urate-Lowering Therapy Use and Efficacy Following Pegloticase Treatment: Findings from a Rheumatology Network Database.

Lissa Padnick-Silver, Andrew Concoff, Hong-Ye Gao

|Jan 10, 2025
Treatment-emergent major adverse cardiovascular and thromboembolic events were infrequent during clinical trials of pegloticase.

Orrin M Troum, Mai Duong, Katie Obermeyer

|Dec 16, 2024
Quality of life and clinical gout assessments during pegloticase with and without methotrexate co-therapy: MIRROR randomized controlled trial exploratory findings.

John Botson, Katie Obermeyer, Brian LaMoreaux

Pageof 3

Frequent Collaborators

5 joint publications

Lissa Padnick-Silver

2 joint publications

Brad Marder

1 joint publications

Naomi Schlesinger

1 joint publications

Dinesh Khanna